BONVINI EZIO,JOHNSON LESLIE S,HUANG LING,MOORE PAUL A,CHICHILI GURUNADH REDDY,ALDERSON RALPH FROMAN
申请号：
IN201617004481
公开号：
IN201617004481A
申请日:
2016.02.08
申请国别(地区):
IN
年份:
2016
代理人:
摘要：
The present invention is directed to sequence optimized CD 123 x CD3 bi specific monovalent diabodies that are capable of simultaneous binding to CD 123 and CD3 and to the uses of such diabodies in the treatment of hematologic malignancies.
